Drug · DIN 02247238
ELIDEL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 20, 2020; first marketed March 24, 2003.
- Drug Identification Number (DIN)
- 02247238
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Pimecrolimus D11AH02
- Class
- Human
- Record last updated
- November 24, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PIMECROLIMUS | 1 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 2, 2011: NOC 12832New Drug Submission (NDS) · Manufacturer Name Change
- March 19, 2003: NOC 3471New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “elidel”. A notice may cover another product or only some lots: read it to see what it covers.
- Archive– Safety Information about Elidel Cream and Protopic OintmentApril 27, 2005 · Drugs